Mesothelioma Blog, Important Mesothelioma Research and information
SearchTags: velcade07th June 2006 : Updated Analysis in Second-Line Treatment of Lung Cancer Trial Confirms Similar Survival for Alimta(R) and DocetaxelAlimta Also Shows Tolerability as Triplet Combination Treatment in First-Line Lung Cancer
Data presented today at the 42nd American Society of Clinical Oncology (ASCO) annual meeting in Atlanta, Ga., affirms that ALIMTA® (pemetrexed), manufactured and m… more » |
|
||||
